Results for tag: "Adlyxin"

Adlyxin (lixisenatide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes. It is a once-daily injectable medication that helps to lower blood sugar levels by increasing the amount of insulin released after meals. Adlyxin is part of a class of drugs known as Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. These drugs can help to regulate blood sugar levels, reduce cholesterol, and treat obesity. Adlyxin is the only GLP-1 receptor agonist approved for use in the United States. It is available in both a prefilled pen and a vial for use with a syringe. Adlyxin is typically used in combination with other diabetes medications, such as metformin, to help control blood sugar levels. The Endocrine and Metabolic Disorders Drugs market is a rapidly growing sector of the pharmaceutical industry. Companies in this market include Sanofi, Novo Nordisk, Eli Lilly, Merck, and AstraZeneca. Show Less Read more